Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00393731 · ClinicalTrials.gov registry record · Phase 2
A Randomized, Control Trial for Preinduction Cervical Ripening
A Phase 2 study, sponsored by The University of Texas Health Science Center, Houston.
- Completed
- Registry status
- Phase 2
- Development phase
- 540
- Enrollment target
NCT00393731 is a Phase 2 study that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 540 participants.
The verdict
NCT00393731, a Phase 2 study, has completed, sponsored by The University of Texas Health Science Center, Houston.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 540 participants
- Enrollment target
Study Summary
The goal of this study is to compare the vaginal delivery rates in women undergoing induction of labor with an unripe cervix between oxytocin induction alone and preinduction cervical ripening with prostaglandin El (misoprostol). Secondary goals are to measure and compare the time intervals to delivery between the two methods.
Interventions
- DRUG Misoprostol
- DRUG oxytocin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 540 participants |
| Start Date | 2004-01 |
| Est. Completion | 2007-08 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00393731
The ClinicalTrials.gov registry entry for NCT00393731 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 540 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Misoprostol is the first listed.
NCT00393731 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00393731 about?
NCT00393731 is a clinical study titled "A Randomized, Control Trial for Preinduction Cervical Ripening". The goal of this study is to compare the vaginal delivery rates in women undergoing induction of labor with an unripe cervix between oxytocin induction alone and preinduction cervical ripening with prostaglandin El (misoprostol). Secondary goals are to measure and compare the time intervals to deliv...
What is the current status of trial NCT00393731?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 540 participants. The study started on 2004-01. Estimated completion is 2007-08.
What interventions are being tested in trial NCT00393731?
The interventions under investigation include: Misoprostol (DRUG), oxytocin (DRUG).
Who is sponsoring clinical trial NCT00393731?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.